Gangliosides inhibit urokinasetype plasminogen activator (uPA)-dependent squamous carcinoma cell migration by preventing uPA receptor/ alphabeta integrin/epidermal growth factor receptor interactions - Wang, XQ (J Invest Dermatol, 2005)
et al.